Published in Ann Thorac Surg on July 01, 2000
Hospital coronary artery bypass graft surgery volume and patient mortality, 1998-2000. Ann Surg (2004) 1.58
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
Changing outcomes of coronary revascularization in British Columbia, 1995-2001. Can J Cardiol (2006) 0.82
Hyperkalemic cardioplegia for adult and pediatric surgery: end of an era? Front Physiol (2013) 0.80
Higher age predicts adverse outcome and readmission after coronary artery bypass grafting. World J Surg (2003) 0.80
Management of postoperative atrial fibrillation and subsequent outcomes in contemporary patients undergoing cardiac surgery: insights from the Society of Thoracic Surgeons CAPS-Care Atrial Fibrillation Registry. Clin Cardiol (2013) 0.79
The effect of total arterial grafting on medium-term outcomes following coronary artery bypass grafting. J Cardiothorac Surg (2007) 0.79
Pre-treatment before coronary artery bypass surgery improves post-operative outcomes in moderate chronic obstructive pulmonary disease patients. Cardiovasc J Afr (2013) 0.78
Complications of pericardiocentesis: A clinical synopsis. Int J Crit Illn Inj Sci (2015) 0.77
Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG. Vasc Health Risk Manag (2010) 0.77
The new cardiac surgery patient: defying previous expectations. Can J Surg (2006) 0.75
Coronary artery bypass surgery in high-risk patients. Curr Control Trials Cardiovasc Med (2005) 0.75
[Experiences collected in more than 2,300 diabetics undergoing coronary artery bypass grafting: patients with a specific risk profile]. Clin Res Cardiol (2006) 0.75
Genome sequence of the plant pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science (2001) 5.16
Assessment of priority for coronary revascularisation procedures. Revascularisation Panel and Consensus Methods Group. Lancet (1990) 4.98
Rapid mapping in Salmonella typhimurium with Mud-P22 prophages. J Bacteriol (1992) 3.29
Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc (1996) 2.11
Can patients with left main stenosis wait for coronary artery bypass grafting? Ann Thorac Surg (1996) 2.04
Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg (1991) 1.73
Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy. Circulation (1997) 1.69
A randomized study of the systemic effects of warm heart surgery. Ann Thorac Surg (1992) 1.58
Cerebral microemboli during cardiopulmonary bypass: increased emboli during perfusionist interventions. Ann Thorac Surg (1999) 1.54
Saccharomyces cerevisiae mutants unresponsive to alpha-factor pheromone: alpha-factor binding and extragenic suppression. Mol Cell Biol (1987) 1.54
Echocardiography and excision of lipomatous hypertrophy of the interatrial septum. Ann Thorac Surg (1999) 1.50
Waiting for coronary revascularization in Toronto: 2 years' experience with a regional referral office. CMAJ (1993) 1.49
Insulin cardioplegia for elective coronary bypass surgery. J Thorac Cardiovasc Surg (2000) 1.44
Technique and pitfalls of retrograde continuous warm blood cardioplegia. Ann Thorac Surg (1991) 1.43
Single lung transplantation and closure of patent ductus arteriosus for Eisenmenger's syndrome. Toronto Lung Transplant Group. J Thorac Cardiovasc Surg (1990) 1.42
The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg (2000) 1.41
Predictors of low cardiac output syndrome after coronary artery bypass. J Thorac Cardiovasc Surg (1996) 1.40
Structures of genes nasA and nasB, encoding assimilatory nitrate and nitrite reductases in Klebsiella pneumoniae M5al. J Bacteriol (1993) 1.40
Autologous pericardial patch without infarctectomy for the treatment of acute cardiac rupture. Can J Cardiol (1995) 1.39
A thioreduction pathway tethered to the membrane for periplasmic cytochromes c biogenesis; in vitro and in vivo studies. J Mol Biol (1997) 1.37
Comparison of the appropriateness of coronary angiography and coronary artery bypass graft surgery between Canada and New York State. JAMA (1994) 1.35
Surgical repair of postinfarction ventricular septal defect. Circulation (1990) 1.35
Clinical performance of Bjork-Shiley mechanical heart valves: a perspective on outlet strut fractures in the 60 degrees and 70 degrees convexo-concave disc models. Can J Cardiol (1988) 1.32
Assigning priority to patients requiring coronary revascularization: consensus principles from a panel of cardiologists and cardiac surgeons. Can J Cardiol (1991) 1.29
Results of combined pulmonary resection and cardiac operation. Ann Thorac Surg (1996) 1.24
Extra-pulmonary manifestations of sarcoidosis. Clin Radiol (2011) 1.20
The nasFEDCBA operon for nitrate and nitrite assimilation in Klebsiella pneumoniae M5al. J Bacteriol (1994) 1.20
Cardiovascular effects of protamine sulfate. Ann Thorac Surg (1969) 1.17
Temporary epicardial pacing after open heart surgery: complications and prevention. J Card Surg (1989) 1.17
Placing patients in the queue for coronary surgery: do age and work status alter Canadian specialists' decisions? J Gen Intern Med (1992) 1.17
Left ventricular mass regression early after aortic valve replacement. Ann Thorac Surg (1996) 1.13
World survey on cardiac pacing. Pacing Clin Electrophysiol (1979) 1.11
The changing pattern of reoperative coronary surgery: trends in 1230 consecutive reoperations. J Thorac Cardiovasc Surg (2000) 1.08
On the death of my father. Pacing Clin Electrophysiol (2000) 1.07
Oxidation-reduction properties of disulfide-containing proteins of the Rhodobacter capsulatus cytochrome c biogenesis system. Biochemistry (2000) 1.07
Placing patients in the queue for coronary revascularization: evidence for practice variations from an expert panel process. Am J Public Health (1990) 1.05
Right and left ventricular systolic function late after repair of tetralogy of Fallot. Am J Cardiol (2000) 1.04
Coronary artery bypass grafting in patients with poor ventricular function. Cardiovascular Surgeons of the University of Toronto. J Thorac Cardiovasc Surg (1992) 1.02
Intraoperative myocardial protection: current trends and future perspectives. Ann Thorac Surg (1999) 1.01
Right ventricular dysfunction following cold potassium cardioplegia. J Thorac Cardiovasc Surg (1985) 1.00
Increased risk of urgent revascularization. J Thorac Cardiovasc Surg (1987) 0.99
Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery. Ann Thorac Surg (2001) 0.98
Central-nervous-system dysfunction after warm or hypothermic cardiopulmonary bypass. Lancet (1992) 0.98
Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia. J Thorac Cardiovasc Surg (1986) 0.97
Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. Ann Thorac Surg (1994) 0.96
Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. Eur J Cardiothorac Surg (1993) 0.96
Elevated insulin-like growth factor-I and transforming growth factor-beta 1 and their receptors in patients with idiopathic hypertrophic obstructive cardiomyopathy. A possible mechanism. Circulation (1998) 0.96
Total correction of tetralogy of Fallot. Review of ten years' experience. Br Heart J (1968) 0.95
Evolution and horizontal transfer of an entire biosynthetic pathway for cytochrome c biogenesis: Helicobacter, Deinococcus, Archae and more. Mol Microbiol (1998) 0.95
Impact of preoperative risk and perioperative morbidity on ICU stay following coronary bypass surgery. Cardiovasc Surg (1996) 0.94
Cardiac pacing following surgery for acquired heart disease. J Card Surg (1997) 0.94
Cardiopulmonary bypass, temperature, and central nervous system dysfunction. Circulation (1994) 0.94
Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg (1995) 0.92
Plastics--a source of chemical contamination in surgical research. Surgery (1966) 0.91
Limitations of blood conservation. J Thorac Cardiovasc Surg (1984) 0.91
Prediction of the annuloplasty ring size in patients undergoing mitral valve repair using real-time three-dimensional transoesophageal echocardiography. Eur J Echocardiogr (2011) 0.91
The radial artery versus the saphenous vein graft in contemporary CABG: a case-matched study. Ann Thorac Surg (2001) 0.90
Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Ann Thorac Surg (2000) 0.90
Current risk of coronary bypass for unstable angina. Eur J Cardiothorac Surg (1991) 0.89
Permanent cardiac pacing after open-heart surgery: acquired heart disease. Pacing Clin Electrophysiol (1984) 0.89
Aneurysm of the hepatic artery: reconstruction with autogenous saphenous vein. J Cardiovasc Surg (Torino) (1975) 0.89
Early outcomes of coronary artery bypass with and without cardiopulmonary bypass in octogenarians. Can J Cardiol (2006) 0.89
Operation for acute postinfarction mitral insufficiency using continuous oxygenated blood cardioplegia. Ann Thorac Surg (1989) 0.89
Cardiac pacing in Canada in 1998: working towards optimal pacing therapy. Canadian Working Group on Cardiac Pacing. Can J Cardiol (1998) 0.88
Hyperacute rejection of heterotopic heart allografts in dogs. Transplantation (1972) 0.88
Comparison between antibiotic irrigation and mobilization of pectoral muscle flaps in treatment of deep sternal infections. J Thorac Cardiovasc Surg (1985) 0.88
Pacemaker-associated thrombotic occlusion of the inferior vena cava causing liver failure. Thorac Cardiovasc Surg (2010) 0.87
Hemodynamic benefits of the Toronto Stentless Valve. J Thorac Cardiovasc Surg (1996) 0.87
Acute aortic dissection type A. Br J Surg (2012) 0.87
The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy. Clin Nephrol (2004) 0.87